SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-013042
Filing Date
2019-03-08
Accepted
2019-03-08 16:36:44
Documents
4
Period of Report
2019-02-17
Items
Item 1.03: Bankruptcy or Receivership
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv515850_8k.htm 8-K 23835
2 EXHIBIT 10.1 tv515850_ex10-1.htm EX-10.1 33966
3 EXHIBIT 10.2 tv515850_ex10-2.htm EX-10.2 7819
4 GRAPHIC image_001.jpg GRAPHIC 3033
  Complete submission text file 0001144204-19-013042.txt   71278
Mailing Address 1 BRIDGE PLAZA N, SUITE 270 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA N, SUITE 270 FORT LEE NJ 07024 201-464-2677
IMMUNE PHARMACEUTICALS INC (Filer) CIK: 0001208261 (see all company filings)

IRS No.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36602 | Film No.: 19669593
SIC: 2834 Pharmaceutical Preparations